Quantification of Degree of Steatosis in Extended Criteria Donor Grafts With Standardized Histologic Techniques: Implications for Graft Survival

被引:29
作者
Frongillo, F. [1 ]
Avolio, A. W. [1 ]
Nure, E. [1 ]
Mule, A. [2 ]
Pepe, G. [1 ]
Magalini, S. C. [1 ]
Agnes, S. [1 ]
机构
[1] Policlin A Gemelli, UO Chirurg Sostitut, Dept Surg, Rome, Italy
[2] Catholic Univ, A Gemelli Hosp, Div Anat Pathol & Histol, Rome, Italy
关键词
LIVER-TRANSPLANTATION; PRIMARY DYSFUNCTION; HEPATIC STEATOSIS; MARGINAL DONORS; EXPERIENCE; RISK;
D O I
10.1016/j.transproceed.2009.03.096
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The gap between the availability of livers from organ donors and the increased demand has led many centers to apply strategies to reduce this deficit. Splitting of cadaveric organs for use in 2 recipients; domino transplantation; and organs from living donors, non-heart-beating donors, and extended-criteria donors (ECDs) are all currently used in orthotopic liver transplantation (OLT). Fatty changes in the donor liver are a risk factor for poor function after OLT; however, the presence of steatosis, frequently present in livers from ECDs, does not exclude the use of these organs. Since January 2000 at our institution, we observed 39 steatotic grafts that were stratified istologically as follows: low steatosis, 5% to 15%; mild steatosis, 16% to 30%; moderate steatosis, 31% to 60%; and severe steatosis (>60%). Histologic techniques can enable identification of the type of fatty change as macrovesicular and microvesicular. These alterations have different effects on primary nonfunction and primary dysfunction. Fifteen grafts, all with severe or moderate, macrovesicular changes were discarded. Twenty-four fatty grafts with low to moderate steatosis were utilized for transplant. Sections from 2 liver biopsies (1 wedge in the left lobe and 1 needle in the right lobe) were stained with hematoxylin-eosin, Masson trichrome, Gomori reticulin, and oil red O. The OLT was performed only in patients with a MELD (Model for End-Stage Liver Disease) score lower than 27. The rate of primary dysfunction was 12.5%, and of primary nonfunction 8.4%. The 6-month graft survival for all fatty livers was 80%. We encourage the careful use of grafts with low to moderate steatosis in recipients without additional risks.
引用
收藏
页码:1268 / 1272
页数:5
相关论文
共 27 条
[1]  
ADAM R, 1991, TRANSPLANT P, V23, P1538
[2]   Normalised intrinsic mortality risk in liver transplantation: European Liver Transplant Registry study [J].
Adam, R ;
Cailliez, V ;
Majno, P ;
Karam, V ;
McMaster, P ;
Calne, RY ;
O'Grady, J ;
Pichlmayr, R ;
Neuhaus, P ;
Otte, JB ;
Hoeckerstedt, K ;
Bismuth, H .
LANCET, 2000, 356 (9230) :621-627
[3]   Effect of graft steatosis on liver function and organ survival after liver transplantation [J].
Angele, Martin K. ;
Rentsch, Markus ;
Hartl, Wolfgang H. ;
Wittmann, Benedikt ;
Graeb, Christian ;
Jauch, Karl Walter ;
Loehe, Florian .
AMERICAN JOURNAL OF SURGERY, 2008, 195 (02) :214-220
[4]  
Angelico M, 2005, Eur Rev Med Pharmacol Sci, V9, P295
[5]   Primary dysfunction after liver transplantation: Donor or recipient fault? [J].
Avolio, AW ;
Agnes, S ;
Chirico, A ;
Castagneto, M .
TRANSPLANTATION PROCEEDINGS, 1999, 31 (1-2) :434-436
[6]   The utility of marginal donors in liver transplantation [J].
Busuttil, RW ;
Tanaka, K .
LIVER TRANSPLANTATION, 2003, 9 (07) :651-663
[7]   Optimal utilization of donor grafts with extended criteria - A single-center experience in over 1000 liver transplants [J].
Cameron, Andrew M. ;
Ghobrial, R. Mark ;
Yersiz, Hasan ;
Fanner, Douglas G. ;
Lipshutz, Gerald S. ;
Gordon, Sherilyn A. ;
Zimmerman, Michael ;
Hong, Johnny ;
Collins, Homas E. ;
Gornbein, Jeffery ;
Amersi, Farin ;
Weaver, Michael ;
Cao, Carlos ;
Chen, Tony ;
Hiatt, Jonathan R. ;
Busuttil, Ronald W. .
ANNALS OF SURGERY, 2006, 243 (06) :748-755
[8]   THE PREDICTIVE VALUE OF DONOR LIVER BIOPSIES FOR THE DEVELOPMENT OF PRIMARY NONFUNCTION AFTER ORTHOTOPIC LIVER-TRANSPLANTATION [J].
DALESSANDRO, AM ;
KALAYOGLU, M ;
SOLLINGER, HW ;
HOFFMANN, RM ;
REED, A ;
KNECHTLE, SJ ;
PIRSCH, JD ;
HAFEZ, GR ;
LORENTZEN, D ;
BELZER, FO .
TRANSPLANTATION, 1991, 51 (01) :157-163
[9]   Nonalcoholic fatty liver disease: From steatosis to cirrhosis [J].
Farrell, GC ;
Larter, CZ .
HEPATOLOGY, 2006, 43 (02) :S99-S112
[10]   Use of livers with microvesicular fat safely expands the donor pool [J].
Fishbein, TM ;
Fiel, MI ;
Emre, S ;
Cubukcu, O ;
Guy, SR ;
Schwartz, ME ;
Miller, CM ;
Sheiner, PA .
TRANSPLANTATION, 1997, 64 (02) :248-251